# A Study of JNJ-64304500 Following Subcutaneous Injection in Healthy Chinese Adult Participants

> **NCT04712006** · PHASE1 · WITHDRAWN · sponsor: **Janssen Research & Development, LLC**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-64304500

## Key facts

- **NCT ID:** NCT04712006
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-05-30
- **Primary completion:** 2021-08-27
- **Final completion:** 2021-10-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor Decision.
- **Last updated:** 2021-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04712006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04712006, "A Study of JNJ-64304500 Following Subcutaneous Injection in Healthy Chinese Adult Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04712006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*